FDA Approved: ONDANSETRON — Original Application (Qilu Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approves the original application for ondansetron from Qilu Pharmaceutical Co., Ltd., enabling the generic product to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting
• Radiation-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

ORIG AP for ONDANSETRON (ONDANSETRON)